Bioactive inorganic nanomaterials for cancer theranostics

Z Pei, H Lei, L Cheng - Chemical Society Reviews, 2023 - pubs.rsc.org
Bioactive materials are a special class of biomaterials that can react in vivo to induce a
biological response or regulate biological functions, thus achieving a better curative effect …

Arsenic: a global environmental challenge

QY Chen, M Costa - Annual Review of Pharmacology and …, 2021 - annualreviews.org
Arsenic is a naturally occurring metalloid and one of the few metals that can be metabolized
inside the human body. The pervasive presence of arsenic in nature and anthropogenic …

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

D Bottomly, N Long, AR Schultz, SE Kurtz, CE Tognon… - Cancer cell, 2022 - cell.com
Acute myeloid leukemia (AML) is a cancer of myeloid-lineage cells with limited therapeutic
options. We previously combined ex vivo drug sensitivity with genomic, transcriptomic, and …

Functional genomic landscape of acute myeloid leukaemia

JW Tyner, CE Tognon, D Bottomly, B Wilmot, SE Kurtz… - Nature, 2018 - nature.com
The implementation of targeted therapies for acute myeloid leukaemia (AML) has been
challenging because of the complex mutational patterns within and across patients as well …

SUMO: from bench to bedside

HM Chang, ETH Yeh - Physiological Reviews, 2020 - journals.physiology.org
Sentrin/small ubiquitin-like modifier (SUMO) is protein modification pathway that regulates
multiple biological processes, including cell division, DNA replication/repair, signal …

Acute promyelocytic leukemia current treatment algorithms

M Yilmaz, H Kantarjian, F Ravandi - Blood cancer journal, 2021 - nature.com
In 1957, Hillestad et al. defined acute promyelocytic leukemia (APL) for the first time in the
literature as a distinct type of acute myeloid leukemia (AML) with a “rapid downhill course” …

Cancer metabolism and tumor microenvironment: fostering each other?

Y Yuan, H Li, W Pu, L Chen, D Guo, H Jiang… - Science China Life …, 2022 - Springer
The changes associated with malignancy are not only in cancer cells but also in
environment in which cancer cells live. Metabolic reprogramming supports tumor cell high …

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

F Lo-Coco, G Avvisati, M Vignetti… - … England Journal of …, 2013 - Mass Medical Soc
Background All-trans retinoic acid (ATRA) with chemotherapy is the standard of care for
acute promyelocytic leukemia (APL), resulting in cure rates exceeding 80%. Pilot studies of …

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

AK Burnett, NH Russell, RK Hills, D Bowen… - The lancet …, 2015 - thelancet.com
Background Acute promyelocytic leukaemia is a chemotherapy-sensitive subgroup of acute
myeloid leukaemia characterised by the presence of the PML–RARA fusion transcript. The …

Pyroptosis and pyroptosis-inducing cancer drugs

F Yang, SN Bettadapura, MS Smeltzer, H Zhu… - Acta Pharmacologica …, 2022 - nature.com
Pyroptosis, an inflammatory form of lytic cell death, is a type of cell death mediated by the
gasdermin (GSDM) protein family. Upon recognizing exogenous or endogenous signals …